The Danish National Multiple Myeloma Registry

Autor: Gimsing P, Holmström MO, Klausen TW, Andersen NF, Gregersen H, Pedersen RS, Plesner T, Pedersen PT, Frederiksen M, Frølund U, Helleberg C, Vangsted A, de Nully Brown P, Abildgaard N

Publikováno v: Clinical Epidemiology, Vol Volume 8, Pp 583-587 (2016)

Peter Gimsing,1 Morten O Holmström,2 Tobias Wirenfelt Klausen,3 Niels Frost Andersen,4 Henrik Gregersen,5 Robert Schou Pedersen,6 Torben Plesner,7 Per Trøllund Pedersen,8 Mikael Frederiksen,9 Ulf Frølund,2 Carsten Helleberg,3 Annette Vangsted,1 Pe

Externí odkaz: https://doaj.org/article/b1595f374813485dacfe63b1e1f1f473

Continued improvement in overall survival in elderly multiple myeloma patients after 2008; a population based study from the Danish Multiple Myeloma Registry

Autor: Abildgaard, N., Vangsted, A., Gregersen, H., Andersen, N.F., Pedersen, R.S., Plesner, T., Pedersen, P.T., Frederiksen, M., Frølund, U., Helleberg, C., Klausen, T.W., Gimsing, P.

Publikováno v: In Clinical Lymphoma Myeloma and Leukemia September 2015 15 Supplement 3:e189-e189

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study.

Autor: Perrot A; Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France., Delimpasi S; General Hospital Evangelismos, Athens, Greece., Spanoudakis E; University General Hospital of Evros-Alexandroupolis District, Alexandroupolis, Greece., Frølund U; Department of Haematology, Zealand University Hospital, Roskilde, Denmark., Belotti A; Hematology Division, ASST Spedali Civili Brescia, Brescia, Italy., Oriol A; Hematology Department, Insitut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain., Moreau P; Hematology Department, University Hospital, Nantes, France., McFadden I; Amgen Inc., Thousand Oaks, CA, USA., Xia Q; Amgen Inc., Thousand Oaks, CA, USA., Arora M; Amgen Inc., Thousand Oaks, CA, USA., Dimopoulos MA; Section of Hematology and Medical Oncology, Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2024 Jun; Vol. 65 (6), pp. 833-842. Date of Electronic Publication: 2024 Mar 18.

Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second-line lenalidomide + dexamethasone induction in multiple myeloma.

Autor: Lund J; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Gruber A; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Lauri B; Department of Internal Medicine, Sunderby Hospital, Luleå, Sweden., Duru AD; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.; Nova Southeastern University (NSU), Fort Lauderdale, Florida., Blimark C; Department of Hematology, Sahlgrenska University Hospital, Gothenburg, Sweden., Swedin A; Department of Hematology, Skåne University Hospital, Lund, Sweden., Hansson M; Department of Hematology, Skåne University Hospital, Lund, Sweden., Forsberg K; Department of Hematology, Norrland University Hospital, Umeå, Sweden., Ahlberg L; Department of Hematology, University Hospital of Linköping, Linköping, Sweden., Carlsson C; Department of Internal Medicine, Hallands Hospital, Halmstad, Sweden., Waage A; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Gimsing P; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Vangsted AJ; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Department of Hematology, Zealand University, Roskilde, Denmark., Frølund U; Department of Hematology, Zealand University, Roskilde, Denmark., Holmberg E; Department of Oncology, Institute of Clinical Sciences, Gothenburg, Sweden., Gahrton G; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Alici E; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Hardling M; Department of Hematology, Uddevalla Hospital, Uddevalla, Sweden., Mellqvist UH; Department of Hematology, Sahlgrenska University Hospital, Gothenburg, Sweden., Nahi H; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.

Publikováno v: Cancer medicine [Cancer Med] 2018 Jun; Vol. 7 (6), pp. 2256-2268. Date of Electronic Publication: 2018 Apr 19.